1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Palivizumab
1.2.3 RSVpreF PF06928316
1.2.4 RSVPreF3 OA (GSK3844766A)
1.2.5 mRNA-1345
1.2.6 Janssen RSV Vaccine
1.2.7 ResVax
1.2.8 Nirsevimab (MEDI8897)
1.2.9 MVA-BN RSV
1.3 Market by Application
1.3.1 Global Respiratory Syncytial Virus Vaccines Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Syncytial Virus Vaccines Market Perspective (2017-2028)
2.2 Respiratory Syncytial Virus Vaccines Growth Trends by Region
2.2.1 Respiratory Syncytial Virus Vaccines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Respiratory Syncytial Virus Vaccines Historic Market Size by Region (2017-2022)
2.2.3 Respiratory Syncytial Virus Vaccines Forecasted Market Size by Region (2023-2028)
2.3 Respiratory Syncytial Virus Vaccines Market Dynamics
2.3.1 Respiratory Syncytial Virus Vaccines Industry Trends
2.3.2 Respiratory Syncytial Virus Vaccines Market Drivers
2.3.3 Respiratory Syncytial Virus Vaccines Market Challenges
2.3.4 Respiratory Syncytial Virus Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue
3.1.1 Global Top Respiratory Syncytial Virus Vaccines Players by Revenue (2017-2022)
3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2017-2022)
3.2 Global Respiratory Syncytial Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Respiratory Syncytial Virus Vaccines Revenue
3.4 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio
3.4.1 Global Respiratory Syncytial Virus Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Syncytial Virus Vaccines Revenue in 2021
3.5 Respiratory Syncytial Virus Vaccines Key Players Head office and Area Served
3.6 Key Players Respiratory Syncytial Virus Vaccines Product Solution and Service
3.7 Date of Enter into Respiratory Syncytial Virus Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Syncytial Virus Vaccines Breakdown Data by Type
4.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Type (2017-2022)
4.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Type (2023-2028)
5 Respiratory Syncytial Virus Vaccines Breakdown Data by Application
5.1 Global Respiratory Syncytial Virus Vaccines Historic Market Size by Application (2017-2022)
5.2 Global Respiratory Syncytial Virus Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
6.2 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
6.3 North America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
7.2 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
8.2 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
8.3 Asia-Pacific Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
9.2 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
9.3 Latin America Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size (2017-2028)
10.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
10.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc.Pfizer Inc.
11.1.1 Pfizer Inc.Pfizer Inc. Company Detail
11.1.2 Pfizer Inc.Pfizer Inc. Business Overview
11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Introduction
11.1.4 Pfizer Inc.Pfizer Inc. Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.1.5 Pfizer Inc.Pfizer Inc. Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Introduction
11.2.4 Sanofi Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.2.5 Sanofi Recent Development
11.3 Merck Sharp & Dohme
11.3.1 Merck Sharp & Dohme Company Detail
11.3.2 Merck Sharp & Dohme Business Overview
11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Introduction
11.3.4 Merck Sharp & Dohme Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.3.5 Merck Sharp & Dohme Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Detail
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Introduction
11.4.4 GlaxoSmithKline Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.4.5 GlaxoSmithKline Recent Development
11.5 SOBI
11.5.1 SOBI Company Detail
11.5.2 SOBI Business Overview
11.5.3 SOBI Respiratory Syncytial Virus Vaccines Introduction
11.5.4 SOBI Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.5.5 SOBI Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Introduction
11.6.4 Johnson & Johnson Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.6.5 Johnson & Johnson Recent Development
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Detail
11.7.2 Bavarian Nordic Business Overview
11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Introduction
11.7.4 Bavarian Nordic Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.7.5 Bavarian Nordic Recent Development
11.8 Novavax
11.8.1 Novavax Company Detail
11.8.2 Novavax Business Overview
11.8.3 Novavax Respiratory Syncytial Virus Vaccines Introduction
11.8.4 Novavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.8.5 Novavax Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Introduction
11.9.4 AstraZeneca Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.9.5 AstraZeneca Recent Development
11.10 Moderna
11.10.1 Moderna Company Detail
11.10.2 Moderna Business Overview
11.10.3 Moderna Respiratory Syncytial Virus Vaccines Introduction
11.10.4 Moderna Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.10.5 Moderna Recent Development
11.11 Codagenix
11.11.1 Codagenix Company Detail
11.11.2 Codagenix Business Overview
11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Introduction
11.11.4 Codagenix Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.11.5 Codagenix Recent Development
11.12 Intravacc
11.12.1 Intravacc Company Detail
11.12.2 Intravacc Business Overview
11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Introduction
11.12.4 Intravacc Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.12.5 Intravacc Recent Development
11.13 Alphavax
11.13.1 Alphavax Company Detail
11.13.2 Alphavax Business Overview
11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Introduction
11.13.4 Alphavax Revenue in Respiratory Syncytial Virus Vaccines Business (2017-2022)
11.13.5 Alphavax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
